HIMS - Hims Hers Health - Stock Forecast

Consumer Defensive - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

HIMS is currently covered by 7 analysts with an average price target of $79.33. This is a potential upside of $15.98 (25.22%) from yesterday's end of day stock price of $63.35.

Hims Hers Health's activity chart (see below) currently has 34 price targets and 63 ratings on display. The stock rating distribution of HIMS is 38.46% BUY, 46.15% HOLD and 15.38% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 78.22% with an average time for these price targets to be met of 358.33 days.

Highest price target for HIMS is $68, Lowest price target is $30, average price target is $30.5.

Most recent stock forecast was given by JAILENDRA SINGH from TRUIST on 17-Jul-2025. First documented stock forecast 12-Feb-2021.

Currently out of the existing stock ratings of HIMS, 15 are a BUY (38.46%), 18 are a HOLD (46.15%), 6 are a SELL (15.38%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$48

$-18.18 (-27.47%)

$33

18 days ago
(17-Jul-2025)

9/9 (100%)

$-1.99 (-3.98%)

618

Buy

$65

1 months 12 days ago
(23-Jun-2025)

4/4 (100%)

$60.4 (1313.04%)

82

Sell

$30

$-36.18 (-54.67%)

$27

2 months 29 days ago
(06-May-2025)

9/9 (100%)

$25.4 (552.17%)

840

Hold

$40

$-26.18 (-39.56%)

$40

2 months 29 days ago
(06-May-2025)

5/5 (100%)

$35.4 (769.57%)

345

Hold

$39

$-27.18 (-41.07%)

$35

2 months 29 days ago
(06-May-2025)

4/4 (100%)

$34.4 (747.83%)

73

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is HIMS (Hims Hers Health) average time for price targets to be met?

On average it took 358.33 days on average for the stock forecasts to be realized with a an average price target met ratio 78.22

Which analyst has the current highest performing score on HIMS (Hims Hers Health) with a proven track record?

RYAN MACDONALD

Which analyst has the most public recommendations on HIMS (Hims Hers Health)?

Ryan Macdonald works at NEEDHAM and has 28 price targets and 21 ratings on HIMS

Which analyst is the currently most bullish on HIMS (Hims Hers Health)?

Sandy Draper with highest potential upside - $7.89

Which analyst is the currently most reserved on HIMS (Hims Hers Health)?

Sean Wieland with lowest potential downside - -$60.18

Hims Hers Health in the News

Trump’s Weight-Loss Experiment Could Aid Lilly, Novo. Cost Is Still a Problem.

The Washington Post reported the CMS is considering a plan that could allow Medicare plans to pay for the drugs. Continue Reading View Comments

Hims & Hers Health, Inc. (HIMS) – Lawmakers Urge Crackdown On Illegal Weight Loss Drugs, Novo’s Termination of Collaboration With HIMS Triggers Securities Class Actions – Hagens Berman

SAN FRANCISCO, Aug. 01, 2025 (GLOBE NEWSWIRE) — On July 25, 2025, investors in Hims & Hers Health, Inc. (NYSE: HIMS) saw the price of their shares significantly fall during intraday trading on reports that U.S. lawmakers urged the FDA to act against copycat versions of weight loss drugs, citing safety concerns. This latest development...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?